Download Files:
Aderamastat
SKU
HY-156963-10 mg
Category Reference compound
Tags Inflammation/Immunology, Metabolic Enzyme/Protease, MMP
$300 – $2,500
Products Details
Product Description
– Aderamastat (FP-025) is an orally active matrix metalloproteinase 12 (MMP-12) inhibitor. Aderamastat can be used for the research of asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis[1].
Web ID
– HY-156963
Shipping
– Room temperature
Molecular Formula
– C21H18N2O4S
References
– [1]Li, Yuhua, et al. Safe administration of MMP-12 inhibitor. Patent. WO2022261624 A1.
CAS Number
– 877176-23-3
Molecular Weight
– 394.44
SMILES
– O=C1NC(C(C2=C(SC3=CC=C(C=C3)OCC4=CC(C)=CC=C4)C=CO2)N1)=O
Clinical Information
– No Development Reported
Research Area
– Inflammation/Immunology
Solubility
– 10 mM in DMSO
Target
– MMP
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.